HHLR Advisors, Ltd. 13D and 13G filings for CELLULAR BIOMEDICINE GROUP, IN:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-06-24 4:38 pm Unchanged | 2020-06-24 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | HHLR Advisors, Ltd. | 235,214 1.200% | 0 (Unchanged) | Filing |
| 2020-03-30 4:15 pm Unchanged | 2020-03-30 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | HHLR Advisors, Ltd. | 235,214 1.200% | 0 (Unchanged) | Filing |
| 2020-02-21 4:10 pm Unchanged | 2020-02-21 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | HHLR Advisors, Ltd. | 235,214 1.200% | 0 (Unchanged) | Filing |